<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myosin has raised an interest in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> research because of its role in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate the expression and clinical relevance of myosin in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (CC) </plain></SENT>
<SENT sid="2" pm="."><plain>Myosin was detected in CC <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with recurrence using matrix-assisted laser desorption/ionization time-of-flight analysis </plain></SENT>
<SENT sid="3" pm="."><plain>An immunohistochemical study was performed using tissue arrays and specific antibodies against myosin heavy chain </plain></SENT>
<SENT sid="4" pm="."><plain>Determinations on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens from 91 patients with resectable CCs were performed </plain></SENT>
<SENT sid="5" pm="."><plain>The minimum follow-up period was of 12.5 years for these patients without <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence </plain></SENT>
<SENT sid="6" pm="."><plain>Western blot and real-time polymerase chain reaction analysis were also performed </plain></SENT>
<SENT sid="7" pm="."><plain>Samples of <z:mp ids='MP_0002038'>carcinomas</z:mp> with recurrence showed an increased expression of myosin </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> with high myosin expression by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell were significantly associated with higher probability of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Our results suggest that myosin expression in CCs is associated with <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> development </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, myosin <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> expression may contribute to an improved prognostic evaluation in patients with CC </plain></SENT>
</text></document>